Clinical improvements were consistent across patient subgroups including age, gender, ethnicity, and IL-36 gene mutation status
There are currently no approved systemic treatments for prurigo nodularis; regulatory filings for prurigo nodularis planned in the first half of 2022
The study was published recently in Genome Medicine, a leading international journal focused on translational, genomic-based medicine
Christian brings a unique level of experience and expertise from a 20-year career at BASF across multiple territories and businesses
The approval is based on new data from cohorts D and K of the KEYNOTE-158 trial
Expanded capabilities across pharma services network accelerate innovation and enhance productivity for customers
Biolexis will also leverage the capabilities of Strides Group for launching this vaccine across regions where the group has a deep market presence and established relationships
Successful proposals will secure fully funded postdoctoral research positions
First approved in 2019, Rinvoq is a JAK inhibitor approved for four indications across gastroenterology, dermatology and rheumatology
DASH enables non-laboratory personnel to insert a nasal swab specimen directly into our test cartridge and then load the cartridge into the DASH instrument, providing an accurate result in about 15 minutes
Subscribe To Our Newsletter & Stay Updated
